EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 12 rujna 2024. Database contains 4821 unique substances/entries.
Filter the list
|
201-706-3
|
86-88-4
|
Acute Tox. 2; Carc. 2 |
|||
|
215-175-0
|
1309-64-4
|
Carc. 2 |
|||
|
232-009-2
|
7783-56-4
|
Acute Tox. 3 |
|||
|
233-047-2
|
10025-91-9
|
Skin Corr. 1B |
|||
|
231-601-8
|
7647-18-9
|
Skin Corr. 1B |
|||
|
-
|
-
|
Acute Tox. 4 |
|||
|
201-549-0
|
84-65-1
|
Carc. 1B |
|||
|
A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300°C to 400°C (572°F to 752°F). Composed primarily of phenanthrene, anthracene and carbazole
|
292-602-7
|
90640-80-5
|
Carc. 1B |
yes |
|
|
The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.
|
292-604-8
|
90640-82-7
|
Carc. 1B; Muta. 1B |
yes |
|
|
The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.
|
292-603-2
|
90640-81-6
|
Carc. 1B; Muta. 1B |
yes |
|
|
A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290°C to 340°C (554°F to 644°F). It contains chiefly trinuclear aromatics and their dihydro derivatives.
|
295-278-5
|
91995-17-4
|
Carc. 1B; Muta. 1B |
yes |
|
|
A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350°C to 360°C (662°F to 680°F). It contains chiefly anthracene, carbazole and phenanthrene.
|
295-276-4
|
91995-16-3
|
Carc. 1B; Muta. 1B |
||
|
A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330°C to 350°C (626°F to 662°F). It contains chiefly anthracene, carbazole and phenanthrene.
|
295-275-9
|
91995-15-2
|
Carc. 1B; Muta. 1B |
yes |
|
|
A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325°C to 365°C (617°F to 689°F). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.
|
295-274-3
|
91995-14-1
|
Carc. 1B |
||
|
204-371-1
|
120-12-7
|
yes |
|||
|
200-539-3
|
62-53-3
|
Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1 |
|||
|
202-910-5
|
101-05-3
|
Eye Irrit. 2; Skin Irrit. 2 |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
433-560-3
|
15375-21-0
|
Repr. 2 |
|||
|
-
|
-
|
P Parasites |
|||
|
show/hide
Amylase, mixed with proteinase, Bacillus thuringiensis-fermented
EC / List no:
-
| CAS no:
68909-36-4
|
-
|
-
|
Resp. Sens. 1 |
||
|
232-565-6
|
9000-90-2
|
Resp. Sens. 1 |
|||
|
223-320-4
|
3825-26-1
|
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1 |
yes |
||
|
-
|
4149-60-4
|
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1 |
yes |
||
|
221-037-0
|
2980-64-5
|
Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
|||
|
232-989-1
|
9080-17-5
|
Skin Corr. 1B |
|||
|
249-415-0
|
29081-56-9
|
Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact. |
|||
|
269-511-6
|
68259-08-5
|
yes |
|||
|
232-235-1
|
7790-98-9
|
Expl. 1.1; Ox. Sol. 1 |
|||
|
221-470-5
|
3108-42-7
|
Carc. 2; Repr. 1B; Lact. |
yes |
||
|
235-185-9
|
12125-01-8
|
Acute Tox. 3 |
|||
|
232-143-1
|
7789-09-5
|
Ox. Sol. 2; Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Acute Tox. 4; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
235-186-4
|
12125-02-9
|
Acute Tox. 4; Eye Irrit. 2 |
|||
|
AIZEN SPILON BLACK TRH; AIZEN SPILON SCHWARZ TRH; THR-1; TRH
|
400-110-2
|
109125-51-1
|
Self-react. C |
||
|
215-676-4
|
1341-49-7
|
Acute Tox. 3; Skin Corr. 1B |
|||
|
441-050-7
|
223705-57-5
|
Skin Irrit. 2; Eye Dam. 1 |
|||
|
700-242-3
|
62037-80-3
|
yes |
|||
|
640 AMMONIUM SALT; KSMIA; S-102; SMIA
|
405-990-1
|
97148-39-5
|
Flam. Sol. 1 |
||
|
231-635-3
|
7664-41-7
|
Flam. Gas 2; Press. Gas; Acute Tox. 3; Skin Corr. 1B |
|||
|
215-647-6
|
1336-21-6
|
Skin Corr. 1B |
|||
|
200-521-5
|
61-82-5
|
Repr. 2; STOT RE 2 |
|||
|
251-375-4
|
33089-61-1
|
Acute Tox. 4; STOT RE 2; Skin Sens. 1 |
|||
|
672-776-4
|
348635-87-0
|
Carc. 2; Eye Irrit. 2 |
|||
|
217-990-7
|
2032-59-9
|
Acute Tox. 3 |
|||
|
263-125-1
|
61790-33-8
|
Acute Tox. 4; Asp. Tox. 1; STOT RE 2; Skin Corr. 1B |
|||
|
268-626-9
|
68131-73-7
|
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
|||
|
268-626-9
|
68131-73-7
|
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
|||
|
262-976-6
|
61788-45-2
|
Asp. Tox. 1; STOT RE 2; Skin Irrit. 2; Eye Dam. 1 |
|||
|
262-977-1
|
61788-46-3
|
Acute Tox. 4; Asp. Tox. 1; STOT SE 3; STOT RE 2; Skin Corr. 1B |
|||